We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Mediclinic International Plc | LSE:MDC | London | Ordinary Share | GB00B8HX8Z88 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 501.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2021 to Apr 2024
TIDMMDC
RNS Number : 9458A
Mediclinic International plc
07 June 2021
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
South African income tax number: 9432434182
("Mediclinic", the "Company", or the "Group")
7 June 2021
NOTIFICATION: TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES & PERSONS CLOSELY ASSOCIATED WITH THEM
This notification sets out the details of awards over ordinary shares in Mediclinic ("Shares") granted to directors and other persons discharging managerial responsibilities ("PDMRs") on 4 June 2021 under the Company's short-term incentive scheme (the "STI") and long-term incentive plan (the "LTIP").
Awards granted under the Company's STI and LTIP
On 4 June 2021, awards over Shares were granted to the following directors and other PDMRs under the Company's STI and LTIP, in accordance with the remuneration policy approved by shareholders in July 2020 (the "Remuneration Policy"):
Hot Features
Premium
Name Director/ Number of Shares Number of Shares
PDMR awarded under awarded under
the FY21 STI the LTIP
Dr Carel Aron van der
Merwe Director 122 614 356 181
----------- ----------------- -----------------
Petrus Jurgens Myburgh Director 80 655 190 569
----------- ----------------- -----------------
David John Hadley PDMR n/a 122 259
----------- ----------------- -----------------
Gert Cornelis Hattingh PDMR n/a 72 993
----------- ----------------- -----------------
Dr Dirk Cornelius le
Roux PDMR n/a 57 158
----------- ----------------- -----------------
Dr Daniel Liedtke PDMR n/a 118 270
----------- ----------------- -----------------
Magnus Oetiker PDMR n/a 96 910
----------- ----------------- -----------------
Koert Hendrik Stefanus
Pretorius PDMR n/a 76 408
----------- ----------------- -----------------
Dr René Toua PDMR n/a 59 487
----------- ----------------- -----------------
Dr Tyson Bruno Welzel PDMR n/a 47 688
----------- ----------------- -----------------
Awards under the STI and LTIP were granted for nil consideration and are based on the average of the middle-market quotations of a Share during a period of five dealing days ending with the dealing day before the day of grant, which equates to GBP3.35 per Share.
STI awards
The Remuneration Committee (the "Committee") considered at length the pay-out under the STI to the executive directors in respect of the financial year ended 31 March 2021 ("FY21"), taking into account financial and overall business performance and the experience of shareholders, employees and clients.
The performance delivered against the pre-defined adjusted EBIT target resulted in a pay-out of 100% of a maximum bonus.
The Committee reviewed the clinical quality, client experience and employee engagement performance for the Group and considered that the formulaic outcome was an appropriate reflection of the Group's overall performance, and the performance and leadership by the executives of the business through COVID-19. However, the Committee was acutely aware that the dividend was likely to remain suspended as part of the Group's broad response to maintaining its liquidity position, and as such, determined that it would be appropriate for the release of the STI to be conditional on the Company's dividend being reinstated. The payment of the cash proportion of the FY21 STI (50%) was therefore deferred until such time. The remaining 50% of the bonus award was deferred into shares, with the awards subject to the reinstatement of the Company's dividend as well as the usual two-year vesting period and continued employment condition under the Remuneration Policy.
Further details on the Committee's decision regarding the FY21 STI are set out in the Remuneration Committee Report included in the Group's Annual Report and Financial Statements for the year ended 31 March 2021 (the "FY21 Annual Report"), which will be published towards the end of June 2021.
LTIP awards
On 4 June 2021, the Committee also granted awards under the Company's LTIP to the Group Chief Executive Office and Group Chief Financial Officer with a face value equivalent to 200% and 150% of salary, respectively (the "FY22 LTIP Awards"). The Committee considered it appropriate to grant awards in line with the normal maximum levels under the Remuneration Policy taking into account share price performance since the grant of FY21 LTIP Awards and the level of stretch included in the performance targets. Awards were also granted to the other members of the Group Executive Committee. The Committee will also use its discretion to amend the vesting outcome where it considers that it is not representative of business performance. This includes consideration of any potential 'windfall gains' at the point of vesting.
Awards granted under the LTIP are structured as conditional awards, with vesting being subject to the satisfaction of performance conditions over a three-year period. Awards granted to the executive directors will be settled in shares upon vesting, and will be subject to a further two-year holding period.
Details of the performance conditions for the FY22 LTIP Awards are set out in the Remuneration Committee Report included in the Group's FY21 Annual Report.
1. Details of PDMR / person closely associated with them
("PCA")
a) Name Dr Carel Aron van der Merwe
----------------------- ---------------------------------------------
2. Reason for the notification
----------------------------------------------------------------------
a) Position / status Group Chief Executive Officer - Mediclinic
International plc
----------------------- ---------------------------------------------
b) Initial notification Initial Notification
/ amendment
----------------------- ---------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------
a) Name Mediclinic International plc
----------------------- ---------------------------------------------
b) LEI 2138002S5BSBIZTD5I60
----------------------- ---------------------------------------------
4.1 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument GB00B8HX8Z88
Identification
Code
----------------------- ---------------------------------------------
b) Nature of the Award over ordinary shares in Mediclinic
transaction International plc granted at nil cost under
the Company's Short-Term Incentive
----------------------- ---------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) GBPnil 122 614
----------
----------------------- ---------------------------------------------
d) Aggregated information
Aggregated volume
Price
122 614
GBPnil
----------------------- ---------------------------------------------
e) Date of the 4 June 2021
transaction
----------------------- ---------------------------------------------
f) Place of the Outside a trading venue
transaction
----------------------- ---------------------------------------------
4.2 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument GB00B8HX8Z88
Identification
Code
----------------------- ---------------------------------------------
b) Nature of the Award over ordinary shares in Mediclinic
transaction International plc granted at nil cost under
the Company's Long-Term Incentive Plan
----------------------- ---------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) GBPnil 356 181
----------
----------------------- ---------------------------------------------
d) Aggregated information
Aggregated volume
Price
356 181
GBPnil
----------------------- ---------------------------------------------
e) Date of the 4 June 2021
transaction
----------------------- ---------------------------------------------
f) Place of the Outside a trading venue
transaction
----------------------- ---------------------------------------------
1. Details of PDMR / person closely associated with them
("PCA")
a) Name Petrus Jurgens Myburgh
----------------------- ---------------------------------------------
2. Reason for the notification
----------------------------------------------------------------------
a) Position / status Group Chief Financial Officer - Mediclinic
International plc
----------------------- ---------------------------------------------
b) Initial notification Initial Notification
/ amendment
----------------------- ---------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------
a) Name Mediclinic International plc
----------------------- ---------------------------------------------
b) LEI 2138002S5BSBIZTD5I60
----------------------- ---------------------------------------------
4.1 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument GB00B8HX8Z88
Identification
Code
----------------------- ---------------------------------------------
b) Nature of the Award over ordinary shares in Mediclinic
transaction International plc granted at nil cost under
the Company's Short-Term Incentive
----------------------- ---------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) GBPnil 80 655
----------
----------------------- ---------------------------------------------
d) Aggregated information
Aggregated volume
Price
80 655
GBPnil
----------------------- ---------------------------------------------
e) Date of the 4 June 2021
transaction
----------------------- ---------------------------------------------
f) Place of the Outside a trading venue
transaction
----------------------- ---------------------------------------------
4.2 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument GB00B8HX8Z88
Identification
Code
----------------------- ---------------------------------------------
b) Nature of the Award over ordinary shares in Mediclinic
transaction International plc granted at nil cost under
the Company's Long-Term Incentive Plan
----------------------- ---------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) GBPnil 190 569
----------
----------------------- ---------------------------------------------
d) Aggregated information
Aggregated volume
Price
190 569
GBPnil
----------------------- ---------------------------------------------
e) Date of the 4 June 2021
transaction
----------------------- ---------------------------------------------
f) Place of the Outside a trading venue
transaction
----------------------- ---------------------------------------------
1. Details of PDMR / person closely associated with them
("PCA")
a) Name David John Hadley
----------------------- ---------------------------------------------
2. Reason for the notification
----------------------------------------------------------------------
a) Position / status Chief Executive Officer - Mediclinic Middle
East
----------------------- ---------------------------------------------
b) Initial notification Initial Notification
/ amendment
----------------------- ---------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------
a) Name Mediclinic International plc
----------------------- ---------------------------------------------
b) LEI 2138002S5BSBIZTD5I60
----------------------- ---------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument GB00B8HX8Z88
Identification
Code
----------------------- ---------------------------------------------
b) Nature of the Award over ordinary shares in Mediclinic
transaction International plc granted at nil cost under
the Company's Long-Term Incentive Plan
----------------------- ---------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) GBPnil 122 259
----------
----------------------- ---------------------------------------------
d) Aggregated information
Aggregated volume
Price
122 259
GBPnil
----------------------- ---------------------------------------------
e) Date of the 4 June 2021
transaction
----------------------- ---------------------------------------------
f) Place of the Outside a trading venue
transaction
----------------------- ---------------------------------------------
1. Details of PDMR / person closely associated with them
("PCA")
a) Name Gert Cornelis Hattingh
----------------------- ---------------------------------------------
2. Reason for the notification
----------------------------------------------------------------------
a) Position / status Group Chief Governance Officer - Mediclinic
International plc
----------------------- ---------------------------------------------
b) Initial notification Initial Notification
/ amendment
----------------------- ---------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------
a) Name Mediclinic International plc
----------------------- ---------------------------------------------
b) LEI 2138002S5BSBIZTD5I60
----------------------- ---------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument GB00B8HX8Z88
Identification
Code
----------------------- ---------------------------------------------
b) Nature of the Award over ordinary shares in Mediclinic
transaction International plc granted at nil cost under
the Company's Long-Term Incentive Plan
----------------------- ---------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) GBPnil 72 993
----------
----------------------- ---------------------------------------------
d) Aggregated information
Aggregated volume
Price
72 993
GBPnil
----------------------- ---------------------------------------------
e) Date of the 4 June 2021
transaction
----------------------- ---------------------------------------------
f) Place of the Outside a trading venue
transaction
----------------------- ---------------------------------------------
1. Details of PDMR / person closely associated with them
("PCA")
a) Name Dr Dirk Cornelius le Roux
----------------------- ---------------------------------------------
2. Reason for the notification
----------------------------------------------------------------------
a) Position / status Group Chief Information Officer - Mediclinic
International plc
----------------------- ---------------------------------------------
b) Initial notification Initial Notification
/ amendment
----------------------- ---------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------
a) Name Mediclinic International plc
----------------------- ---------------------------------------------
b) LEI 2138002S5BSBIZTD5I60
----------------------- ---------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument GB00B8HX8Z88
Identification
Code
----------------------- ---------------------------------------------
b) Nature of the Award over ordinary shares in Mediclinic
transaction International plc granted at nil cost under
the Company's Long-Term Incentive Plan
----------------------- ---------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) GBPnil 57 158
----------
----------------------- ---------------------------------------------
d) Aggregated information
Aggregated volume
Price
57 158
GBPnil
----------------------- ---------------------------------------------
e) Date of the 4 June 2021
transaction
----------------------- ---------------------------------------------
f) Place of the Outside a trading venue
transaction
----------------------- ---------------------------------------------
1. Details of PDMR / person closely associated with them
("PCA")
a) Name Dr Daniel Liedtke
----------------------- ---------------------------------------------
2. Reason for the notification
----------------------------------------------------------------------
a) Position / status Chief Executive Officer: Hirslanden
----------------------- ---------------------------------------------
b) Initial notification Initial Notification
/ amendment
----------------------- ---------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------
a) Name Mediclinic International plc
----------------------- ---------------------------------------------
b) LEI 2138002S5BSBIZTD5I60
----------------------- ---------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument GB00B8HX8Z88
Identification
Code
----------------------- ---------------------------------------------
b) Nature of the Award over ordinary shares in Mediclinic
transaction International plc granted at nil cost under
the Company's Long-Term Incentive Plan
----------------------- ---------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) GBPnil 118 270
----------
----------------------- ---------------------------------------------
d) Aggregated information
Aggregated volume
Price
118 270
GBPnil
----------------------- ---------------------------------------------
e) Date of the 4 June 2021
transaction
----------------------- ---------------------------------------------
f) Place of the Outside a trading venue
transaction
----------------------- ---------------------------------------------
1. Details of PDMR / person closely associated with them
("PCA")
a) Name Magnus Oetiker
----------------------- ---------------------------------------------
2. Reason for the notification
----------------------------------------------------------------------
a) Position / status Group Chief Strategy and Human Resources
Officer - Mediclinic International plc
----------------------- ---------------------------------------------
b) Initial notification Initial Notification
/ amendment
----------------------- ---------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------
a) Name Mediclinic International plc
----------------------- ---------------------------------------------
b) LEI 2138002S5BSBIZTD5I60
----------------------- ---------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument GB00B8HX8Z88
Identification
Code
----------------------- ---------------------------------------------
b) Nature of the Award over ordinary shares in Mediclinic
transaction International plc granted at nil cost under
the Company's Long-Term Incentive Plan
----------------------- ---------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) GBPnil 96 910
----------
----------------------- ---------------------------------------------
d) Aggregated information
Aggregated volume
Price
96 910
GBPnil
----------------------- ---------------------------------------------
e) Date of the 4 June 2021
transaction
----------------------- ---------------------------------------------
f) Place of the Outside a trading venue
transaction
----------------------- ---------------------------------------------
1. Details of PDMR / person closely associated with them
("PCA")
a) Name Koert Hendrik Stefanus Pretorius
----------------------- ----------------------------------------------
2. Reason for the notification
-----------------------------------------------------------------------
a) Position / status Chief Executive Officer - Mediclinic Southern
Africa
----------------------- ----------------------------------------------
b) Initial notification Initial Notification
/ amendment
----------------------- ----------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------
a) Name Mediclinic International plc
----------------------- ----------------------------------------------
b) LEI 2138002S5BSBIZTD5I60
----------------------- ----------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-----------------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument GB00B8HX8Z88
Identification
Code
----------------------- ----------------------------------------------
b) Nature of the Award over ordinary shares in Mediclinic
transaction International plc granted at nil cost under
the Company's Long-Term Incentive Plan
----------------------- ----------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) GBPnil 76 408
----------
----------------------- ----------------------------------------------
d) Aggregated information
Aggregated volume
Price
76 408
GBPnil
----------------------- ----------------------------------------------
e) Date of the 4 June 2021
transaction
----------------------- ----------------------------------------------
f) Place of the Outside a trading venue
transaction
----------------------- ----------------------------------------------
1. Details of PDMR / person closely associated with them
("PCA")
a) Name Dr René Toua
----------------------- ---------------------------------------------
2. Reason for the notification
----------------------------------------------------------------------
a) Position / status Group Chief Clinical Officer - Mediclinic
International plc
----------------------- ---------------------------------------------
b) Initial notification Initial Notification
/ amendment
----------------------- ---------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------
a) Name Mediclinic International plc
----------------------- ---------------------------------------------
b) LEI 2138002S5BSBIZTD5I60
----------------------- ---------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument GB00B8HX8Z88
Identification
Code
----------------------- ---------------------------------------------
b) Nature of the Award over ordinary shares in Mediclinic
transaction International plc granted at nil cost under
the Company's Long-Term Incentive Plan
----------------------- ---------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) GBPnil 59 487
----------
----------------------- ---------------------------------------------
d) Aggregated information
Aggregated volume
Price
59 487
GBPnil
----------------------- ---------------------------------------------
e) Date of the 4 June 2021
transaction
----------------------- ---------------------------------------------
f) Place of the Outside a trading venue
transaction
----------------------- ---------------------------------------------
1. Details of PDMR / person closely associated with them
("PCA")
a) Name Dr Tyson Bruno Welzel
----------------------- ---------------------------------------------
2. Reason for the notification
----------------------------------------------------------------------
a) Position / status Group Chief Innovation Officer - Mediclinic
International plc
----------------------- ---------------------------------------------
b) Initial notification Initial Notification
/ amendment
----------------------- ---------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------
a) Name Mediclinic International plc
----------------------- ---------------------------------------------
b) LEI 2138002S5BSBIZTD5I60
----------------------- ---------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument GB00B8HX8Z88
Identification
Code
----------------------- ---------------------------------------------
b) Nature of the Award over ordinary shares in Mediclinic
transaction International plc granted at nil cost under
the Company's Long-Term Incentive Plan
----------------------- ---------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) GBPnil 47 688
----------
----------------------- ---------------------------------------------
d) Aggregated information
Aggregated volume
Price
47 688
GBPnil
----------------------- ---------------------------------------------
e) Date of the 4 June 2021
transaction
----------------------- ---------------------------------------------
f) Place of the Outside a trading venue
transaction
----------------------- ---------------------------------------------
About Mediclinic International plc
Mediclinic is a diversified international private healthcare services group, established in South Africa in 1983, with divisions in Switzerland, Southern Africa (South Africa and Namibia) and the United Arab Emirates ("UAE").
The Group's core purpose is to enhance the quality of life.
Its vision is to be the partner of choice that people trust for all their healthcare needs.
Mediclinic is focused on providing specialist-orientated, multi-disciplinary services across the continuum of care in such a way that the Group will be regarded as the most respected and trusted provider of healthcare services by patients, medical practitioners, funders and regulators of healthcare in each of its markets.
At 31 March 2021, Mediclinic comprised 74 hospitals, five subacute hospitals, two mental health facilities, 18 day case clinics and 18 outpatient clinics. Hirslanden operated 17 hospitals and four day case clinics in Switzerland with more than 1 900 inpatient beds; Mediclinic Southern Africa operations included 50 hospitals (three of which in Namibia), five sub-acute hospitals, two mental health facilities and 12 day case clinics (four of which operated by Intercare) across South Africa, and around 8 600 inpatient beds; and Mediclinic Middle East operated seven hospitals, two day case clinics and 18 outpatient clinics with more than 900 inpatient beds in the UAE. In addition, under management contracts, Mediclinic Middle East operates one hospital in Abu Dhabi and will open a 200-bed hospital in the Kingdom of Saudi Arabia in mid-2022.
The Company's primary listing is on the London Stock Exchange ("LSE") in the United Kingdom, with secondary listings on the JSE in South Africa and the Namibian Stock Exchange in Namibia.
Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a leading private healthcare group based in the United Kingdom and listed on the LSE.
For further information, please contact:
Company Secretary, Link Company Matters Limited
Caroline Emmet
+44 (0)333 300 1930
Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181
Media queries
FTI Consulting
Ben Atwell/Ciara Martin - United Kingdom
+44 (0)20 3727 1000
Sherryn Schooling - South Africa
+27 (0)21 487 9000
Registered address : 6(th) Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom
Website: www.mediclinic.com
Corporate broker (United Kingdom) : Morgan Stanley & Co International plc and UBS Investment Bank
JSE sponsor (South Africa): Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor (Namibia): Simonis Storm Securities (Pty) Ltd
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBLGDLDUGDGBS
(END) Dow Jones Newswires
June 07, 2021 05:00 ET (09:00 GMT)
1 Year Mediclinic Chart |
1 Month Mediclinic Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
